Home > Insider Trading > Filing (0001140361-16-079947)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1370042	Stonepine Capital, L.p.	919 Nw Bond Street Suite 204 Bend OR 97703		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-09-13	61,704	$1.54	5,706,704	No	4	P	Direct
Common Stock	Acquisiton	2016-09-14	56,864	$1.55	5,763,568	No	4	P	Direct
Common Stock	Acquisiton	2016-09-15	14,928	$1.55	5,778,496	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The filers (the "Filers") are Stonepine Capital, L.P. (the "Fund"), Stonepine Capital Management, LLC (the "General Partner"), Jon M. Plexico and Timothy P. Lynch. The General Partner is the general partner and investment adviser of the Fund. Mr. Plexico and Mr. Lynch are the General Partner's managers and control persons. These securities are held directly by the Fund for the benefit of its investors and are indirectly beneficially owned by the General Partner and Mr. Plexico and Mr. Lynch as the General Partner's control persons. The Fund is filing this Form 4 for itself and the other Filers.
The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each Filer disclaims beneficial ownership of these securities except to the extent of that Filer's pecuniary interest therein.